The authors concluded that miR-122-5p-loaded exosomes represent a novel therapeutic strategy for treating DHT-induced hair loss, with the potential to reverse AGA progression by targeting TGF-β1/SMAD3 signaling (Level V). The gene discussed is TGFB1; the disease is alopecia.